Skip Navigation



NDT Advance Access published online on May 29, 2008

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfn308
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
23/11/3635    most recent
gfn308v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Merino, A.
Right arrow Articles by Aljama, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merino, A.
Right arrow Articles by Aljama, P.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2008]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org



Bacterial DNA and endothelial damage in haemodialysis patients

Ana Merino, Sonia Nogueras, Tania García-Maceira, Mariano Rodríguez, Alejandro Martin-Malo, Rafael Ramirez, Julia Carracedo* and Pedro Aljama*

Unidad de Investigación, Servicio de Nefrología, Hospital Universitario Reina Sofía, Córdoba 14004, Spain

Correspondence and offprint requests to: Julia Carracedo, Unidad de Investigación, Hospital Universitario Reina Sofía, Avda Menendez Pidal S/N, Córdoba 14004, Spain. Tel: +34-957-010452; Fax: +34-957-010452; E-mail: julia.carracedo.exts{at}juntadeandalucia.es



  Abstract

Background. An increased percentage of CD14+CD16+ activated monocytes have been reported in peripheral blood from haemodialysis patients. The aim of this study is to investigate if a mild stimulus such as bacterial DNA (CpG-ODNs) contamination may induce an inflammatory response in CD14+CD16+ monocytes from haemodialysis patients and to value the biological consequences of this inflammatory response on endothelial cell damage.

Methods. Circulating mononuclear cells from 20 haemodialysis patients and 15 healthy subjects were studied. CD14+CD16+ and the toll-like receptor 9 (TLR-9) expression were assessed by flow cytometry. Cell culture inserts were used to evaluate the effect of CD14+CD16+ and CpG-ODNs on endothelial cell apoptosis (measured by Tunnel). Intracellular cytokines were measured by Cytometric methods. NF-{kappa}B, p38 MAPK, c-Jun PI3K and MEK1/2 activity were modified by specific peptides.

Results. At baseline, CD14+CD16+ have an increased expression of cytoquines and TLR-9. CpG-ODNs caused the production and release of cytoquines in CD14+CD16+, but not in CD14++ monocytes. This inflammatory response was mediated by intracellular signalling dependent on NF-{kappa}B, p38 MARK or c-Jun PI3K but not by MEK1/2 activation. The results of the present study also demonstrate that the inflammatory response induced by the stimulation of CD14+CD16+ by CpG DNA resulted in endothelial cell apoptosis.

Conclusions. The results of the present study demonstrate that in haemodialysis patients there is a subpopulation of pre-activated monocytes that can be stimulated by contaminant bacterial DNA. These activated cells produce and release inflammatory factors that may cause endothelial injury.

Keywords: bacterial DNA; endothelial damage; haemodialysis; inflammation; monocytes


* Both authors are considered co-directors of this study.

Received for publication: 15. 1.08
Accepted in revised form: 7. 5.08


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.